Cell-based approaches for the treatment of systemic inflammation

Nephrology Dialysis Transplantation

Volumn 28, Issue 2, 2013, Pages 296-302

  Pino, Christopher J ^a   Yevzlin, Alexander S ^b   Lee, Kyungsoo ^c   Westover, Angela J ^a   Smith, Peter L ^a   Buffington, Deborah A ^a   David Humes, H ^a,c,d  

^a Innovative BioTherapies Inc   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d CytoPherx Inc   (United States)

Author keywords

acute kidney injury (AKI); cell therapy; selective cytopheretic inhibitory device (SCD); stem progenitor cells; systemic inflammation

Indexed keywords

CYTOKINE;

ACUTE KIDNEY FAILURE; CELL THERAPY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); HUMAN; IMMUNOMODULATION; INFLAMMATION; KIDNEY EPITHELIUM; LEUKOCYTE; MEDICAL DEVICE; MONOCYTE; MORTALITY; MULTIPLE ORGAN FAILURE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SELECTIVE CYTOPHERETIC DEVICE;

ACUTE KIDNEY INJURY; HUMANS; IMMUNOMODULATION; INFLAMMATION; MULTIPLE ORGAN FAILURE; STEM CELLS; TISSUE THERAPY;

EID: 84874527721     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs503     Document Type: Review

References (33)

1. Pinsky MR, Vincent JL, Deviere J et al. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993; 103: 565-575 (Pubitemid 23070764)
2. Munoz C, Carlet J, Fitting C et al. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991; 88: 1747-1754
3. Astiz M, Saha D, Lustbader D et al. Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis. J Lab Clin Med 1996; 128: 594-600 (Pubitemid 27506766)
4. Deneke SM, Fanburg BL. Regulation of cellular glutathione. Am J Physiol 1989; 257(4 Pt 1): L163-L173
5. Beale R, Reinhart K, Brunkhorst FM et al. Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry. Infection 2009; 37: 222-232
6. Vincent JL, Sakr Y, Sprung CL et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006; 34: 344-353 (Pubitemid 43145611)
7. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138-150 (Pubitemid 36056721)
8. Brown KA, Brain SD, Pearson JD et al. Neutrophils in development of multiple organ failure in sepsis. Lancet 2006; 368: 157-169
9. Schouten M, Wiersinga WJ, Levi M et al. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008; 83: 536-545 (Pubitemid 351966862)
10. Kaneider NC, Leger AJ, Kuliopulos A. Therapeutic targeting of molecules involved in leukocyte-endothelial cell interactions. FEBS J 2006; 273: 4416-4424 (Pubitemid 44401593)
11. Maroszynska I, Fiedor P. Leukocytes and endothelium interaction as rate limiting step in the inflammatory response and a key factor in the ischemia-reperfusion injury. Ann Transplant 2000; 5: 5-11
12. Atan R, Crosbie D, Bellomo R. Techniques of extracorporeal cytokine removal: a systematic review of the literature. Blood Purif 2012; 33: 88-100
13. Marshall JC. Neutrophils in the pathogenesis of sepsis. Crit Care Med 2005; 33(12 Suppl): S502-S505 (Pubitemid 41786001)
14. Boxer LA. Neutrophil abnormalities. Pediatr Rev 2003; 24: 52-62
15. Hughes WT, Armstrong D, Bodey GP et al. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis 1997; 25: 551-573 (Pubitemid 127774275)
16. Bloembergen WE, Stannard DC, Port FK et al. Relationship of dose of hemodialysis and cause-specific mortality. Kidney Int 1996; 50: 557-565 (Pubitemid 26274385)
17. Allon M, Depner TA, Radeva M et al. Impact of dialysis dose and membrane on infection-related hospitalization and death: Results of the HEMO Study. J Am Soc Nephrol 2003; 14: 1863-1870 (Pubitemid 36750482)
18. Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000; 58: 1758-1764
19. Stenvinkel P, Ketteler M, Johnson RJ et al. IL-10, IL-6, and TNFalpha: central factors in the altered cytokine network of uremia-the good, the bad, and the ugly. Kidney Int 2005; 67: 1216-1233 (Pubitemid 40463099)
20. Humes HD, Buffington DA, MacKay SM et al. Replacement of renal function in uremic animals with a tissue-engineered kidney. Nat Biotechnol 1999; 17: 451-455 (Pubitemid 29217896)
21. Tumlin J, Wali R, Williams W et al. Efficacy and safety of renal tubule cell therapy for acute renal failure. J Am Soc Nephrol 2008; 19: 1034-1040
22. Humes HD, Buffington DA, Lou L et al. Cell therapy with a tissueengineered kidney reduces the multiple-organ consequences of septic shock. Crit Care Med 2003; 31: 2421-2428 (Pubitemid 37281724)
23. Humes HD, Sobota JT, Ding F et al. A selective cytopheretic inhibitory device to treat the immunological dysregulation of acute and chronic renal failure. Blood Purif 2010; 29: 183-190
24. Mariano F, Tedesch L, Morselli M et al. Normal citratemia and metabolic tolerance of citrate anticoagulation for hemodiafiltration in severe septic shock burn patients. Intensive Care Med 2010; 36: 1735-1743
25. Ding F, Song JH, Jung JY et al. A biomimetic membrane device that modulates the excessive inflammatory response to sepsis. PLoS One 2011; 6: e18584
26. Ayub K, Hallett MB. Ca2+ influx shutdown during neutrophil apoptosis: importance and possible mechanism. Immunology 2004; 111: 8-12 (Pubitemid 38091043)
27. Ding F, Yevzlin AS, Xu ZY et al. The effects of a novel therapeutic device on acute kidney injury outcomes in the intensive care unit: a pilot study. ASAIO J 2011; 57: 426-432
28. Tumlin J, Chawla L, Tolwani AJ et al. The effect of the selective cytopheretic device on acute kidney injury outcomes in the intensive care unit: a multi-center pilot study. Semin Dial 2012; 25(6) DOI: 10.1111/sdi.12032. (accepted for publication).
29. Mehta RL, Pascual MT, Soroko S et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int 2004; 66: 1613-1621 (Pubitemid 39298397)
30. Zarbock A, Singbartl K, Ley K. Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest 2006; 116: 3211-3219 (Pubitemid 44878635)
31. Buffington D, Pino CJ, Chen L et al. Bioartificial renal epithelial cell system (BRECS): a compact, cryopreservable extracorporeal renal replacement device. Cell Med 2012; 4: 33-43
32. Pino CJ, Humes HD (eds). Bioartificial Kidney. Comprehensive Biomaterials. Vol. 6. Oxford, UK: Elsevier, 2011
33. Nikolovski J, Gulari E, Humes HD. Design engineering of a bioartificial renal tubule cell therapy device. Cell Transplant 1999; 8: 351-364 (Pubitemid 29409602)